Jun 1, 2026 07:30AM
Jun 1, 2026 07:30AM
May 11, 2026 07:30AM
Apr 27, 2026 02:50PM
Apr 27, 2026 10:10AM
Apr 27, 2026 07:03AM
Apr 27, 2026 07:00AM Intellia reports positive phase 3 results for gene editing HAE treatment
Apr 27, 2026 07:00AM
Apr 27, 2026 07:00AM
Apr 8, 2026 09:15AM
Mar 4, 2026 06:01AM
Mar 3, 2026 09:54AM
Mar 3, 2026 07:30AM
Mar 3, 2026 07:30AM Intellia Therapeutics Presents Longer-Term Clinical Data for Lonvoguran Ziclumeran (lonvo-z); Hereditary Angioedema (HAE) Patient-Focused Research at AAAAI 2026
Mar 3, 2026 04:56AM
Mar 2, 2026 03:25PM
Mar 2, 2026 02:48PM
Mar 2, 2026 02:18PM
Mar 2, 2026 02:04PM
Mar 2, 2026 12:28PM
Mar 2, 2026 12:05PM William Blair Upgrades Intellia Therapeutics (NTLA) to Outperform
Mar 2, 2026 10:25AM
Mar 2, 2026 07:30AM
Mar 2, 2026 07:30AM
Feb 26, 2026 01:28PM
Feb 26, 2026 07:30AM
Jan 27, 2026 11:29AM
Jan 27, 2026 08:00AM FDA lifts clinical hold on Intellia's ATTRv-PN gene therapy trial
Jan 27, 2026 08:00AM
Dec 19, 2025 09:06AM
Nov 18, 2025 08:45AM
Nov 10, 2025 03:17PM
Nov 10, 2025 03:17PM
Nov 8, 2025 05:13PM
Nov 8, 2025 05:13PM Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
Nov 7, 2025 08:56AM
Nov 6, 2025 04:00PM
Oct 31, 2025 09:54AM
Oct 31, 2025 07:27AM
Oct 30, 2025 04:55AM
Oct 29, 2025 04:24PM
Oct 28, 2025 06:26AM Canaccord Genuity Reiterates Buy Rating on Intellia Therapeutics (NTLA)
Oct 27, 2025 07:31AM
Oct 27, 2025 07:30AM
Sep 18, 2025 07:30AM
Sep 18, 2025 07:30AM
Aug 30, 2025 04:00PM
Jun 15, 2025 10:45AM
May 29, 2025 07:49AM Bernstein on Intellia Therapeutics (NTLA): 'Investor Perception Takes Another Big Hit'
May 8, 2025 07:30AM

322,090 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All